mCig Inc. Launches VitaCBD Product Line, Provides Product Update for the Holiday Season

BEVERLY HILLS, CA--(Marketwired - Nov 12, 2015) - mCig, Inc. (the "Company") (OTCQB: MCIG), a leading distributor of innovative products, technologies, and services for the global medical and legal recreational cannabis industry, releases its new scientifically formulated Organic Grade Hemp CBD (Cannabidiol) Oil for sale now at the e-Commerce store www.vitacbd.com.

Mr. Paul Rosenberg, President and CEO of MCIG, stated the company has been working diligently to develop, bring to market, and merchandise a number of products including the new VitaCBD™ brand featuring the Organic Grade Hemp CBD Oil. CBD (Cannabidiol) is a natural constituent of hemp oil and is legal to consume, possess, and sell in the U.S.A. and over 40 countries around the world as a dietary and wellness supplement.

All Natural Organic Grade Hemp CBD Oils contain a perfected blend of CBD-rich hemp oil and terpenes and are created for those desiring a pure taste and an all-natural way to ingest the dietary supplement. These delicious Organic Grade Hemp CBD (Cannabidiol) Oil drops (tinctures) are available to order now in the following tincture sizes:

1. Original or Strawberry tinctures 10ml bottle containing 100mg CBD

2. Original or Strawberry tinctures 10ml bottle containing 350mg CBD

3. Original or Strawberry tinctures 15ml bottle containing 500mg CBD

The company also introduces its Gold Label VitaCBD™ product that provides a more direct approach to taking CBD without any carriers, sweeteners, or flavors. Each non-standardized 3g Gold oral syringe delivers between 684-780mg of CBD.

Next month the company will launch a new MCIG-branded CBD vape pen along with 3 new All Natural Flavored High Grade Hemp CBD Vape Oils (E-Juices) just in time for the holiday shopping season.

MCIG releases these new products for those consumers looking for the best High Grade Hemp CBD Oil tinctures and Vape E-Liquids (E-Juices) that carry all the phytonutrients, flavonoids, terpenes, essential fatty acids, vitamins, and other nutrients important for body function.

MCIG invites all interested parties to contact the company at http://vitacbd.com/wholesale-registration/ in order to secure its Organic Grade Hemp CBD (Cannabidiol) Oil in bulk for wholesale, resale, or distribution. MCIG can help any size company to initiate product formulation, mix and label bottles, and launch a product line. You can view, research, and purchase VitaCBD™ Organic Grade CBD (Cannabidiol) Rich Hemp Oil at http://vitacbd.com/shop/ or join the mailing list for a 15% off coupon for the remainder of 2015!

"We're very excited to reveal the latest addition to our product line. Our continual commitment of creating high quality products enables our goals for expansion and growth," added Paul Rosenberg, President and CEO of mCig, Inc.

About mCig, Inc.

Headquartered in Beverly Hills, CA, mCig, Inc. (OTCQB: MCIG) is a leading provider of advanced technologies and solutions to the global cannabis industry. mCig manufactures and markets best-selling portable and home vaporizers, extraction related equipment, CBD Rich Hemp Oil-derived products, and related nutraceuticals based on natural compounds found in Cannabis and Hemp plants. The company owns the mCig and Vapolution brands, and has a 47% stake in VitaCig (VTCQ), makers of the VitaStik, a disposable vitamin vaporizer. The company believes that a well-regulated marijuana industry is emerging as more states follow the lead of Alaska, Colorado, Oregon, and Washington in legalizing marijuana. A similar trend is developing within the CBD and Hemp industries following overwhelming consumer demand.

Safe Harbor Statement

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company's ability to develop, market and sell products based on its technology; the expected benefits and efficacy of the Company's products and technology; the availability of substantial additional funding for the Company to continue its operations and to conduct research and development, and future product commercialization; and the Company's business, research, product development, regulatory approval, marketing and distribution plans and strategies.